These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 3054233

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The role of calcium in the regulation of normal vascular tone and in arterial hypertension].
    Ramón de Berrazueta J.
    Rev Esp Cardiol; 1999; 52 Suppl 3():25-33. PubMed ID: 10614146
    [Abstract] [Full Text] [Related]

  • 24. [Insulin resistance and arterial hypertension].
    Weidmann P, Müller-Wieland D, de Courten M, Krone W.
    Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473
    [Abstract] [Full Text] [Related]

  • 25. Alpha 2-adrenergic receptors and calcium: alpha 2-receptor blockade in vascular smooth muscle as an approach to the treatment of hypertension.
    Lee JY, DeBernardis JF.
    Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):213-25. PubMed ID: 1972206
    [Abstract] [Full Text] [Related]

  • 26. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ, Schalekamp MA.
    Postgrad Med J; 1983 Apr; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [Abstract] [Full Text] [Related]

  • 27. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.
    Bolli P, Erne P, Hulthén UL, Ritz R, Kiowski W, Ji BH, Bühler FR.
    J Cardiovasc Pharmacol; 1984 Apr; 6 Suppl 7():S996-1001. PubMed ID: 6085391
    [Abstract] [Full Text] [Related]

  • 28. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 29. A modern plan for treating hypertension.
    Laragh JH.
    Health Psychol; 1988 Apr; 7 Suppl():253-65. PubMed ID: 3072181
    [Abstract] [Full Text] [Related]

  • 30. Reversal of renovascular hypertension: a comparison of changes in blood pressure, plasma renin, and sodium balance in two models in rats.
    Godfrey N, Kumar A, Bing RF, Swales JD, Thurston H.
    J Lab Clin Med; 1985 Jun; 105(6):679-85. PubMed ID: 3889199
    [Abstract] [Full Text] [Related]

  • 31. Structural changes and cyclic GMP content of the aorta after calcium antagonism or angiotensin converting enzyme inhibition in renovascular hypertensive rats.
    Véniant M, Gray GA, Heudes D, Ménard J, Clozel JP.
    J Hypertens; 1995 Jul; 13(7):731-7. PubMed ID: 7594436
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 34. Effects of altered dietary calcium intake in experimental hypertension: role of intracellular free magnesium.
    Resnick LM, Gupta RK, Sosa RE, Corbett ML, Sealey JE, Laragh JH.
    J Hypertens Suppl; 1986 Dec; 4(5):S182-5. PubMed ID: 3553472
    [Abstract] [Full Text] [Related]

  • 35. Abnormal sodium metabolism and plasma renin activity (renal renin secretion) and the vasoconstriction volume hypothesis: implications for pathogenesis and treatment of hypertension and its vascular consequences (heart attack, stroke).
    Laragh JH, Sealey JE.
    Clin Chem; 1991 Oct; 37(10 Pt 2):1820-7. PubMed ID: 1914196
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Acute hypertension and calcium-channel blockers.
    Kanneganti M, Halpern NA.
    New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271
    [Abstract] [Full Text] [Related]

  • 38. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J, Henik RA, Brownfield M, Armstrong J.
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S, Takeyama K, Fukuya F, Nagai R, Hosoki K, Nishimura K, Deguchi T, Karasawa T.
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.